96363-20-1 Usage
Description
3-N-Boc-Amino-3-(4-methoxyphenyl)propionic acid, also known as 3-[(tert-Butoxycarbonyl)amino]-3-(4-methoxyphenyl)propanoic Acid, is a white to off-white powdery compound with significant potential in the field of medicinal chemistry. It is characterized by its unique structure, which includes a Boc-protected amino group and a 4-methoxyphenyl moiety attached to a propionic acid backbone. 3-N-Boc-Amino-3-(4-methoxyphenyl)propionic acid is particularly valuable for the synthesis and study of antitumor activity of peptidyl epoxyketone proteasome inhibitors that are composed of β-amino acids.
Uses
Used in Pharmaceutical Industry:
3-N-Boc-Amino-3-(4-methoxyphenyl)propionic acid is used as a key intermediate in the synthesis of peptidyl epoxyketone proteasome inhibitors for their antitumor activity. These inhibitors are designed to target and inhibit the activity of proteasomes, which are essential protein complexes involved in the degradation of cellular proteins. By disrupting the function of proteasomes, these inhibitors can effectively suppress the growth and proliferation of cancer cells, making them a promising therapeutic strategy for various types of cancer.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-N-Boc-Amino-3-(4-methoxyphenyl)propionic acid serves as a valuable compound for the study and development of novel antitumor agents. Researchers can utilize this compound to explore the structure-activity relationships of peptidyl epoxyketone proteasome inhibitors and identify potential modifications that may enhance their efficacy and selectivity. This knowledge can contribute to the design of more effective and targeted cancer therapies.
Used in Drug Development:
3-N-Boc-Amino-3-(4-methoxyphenyl)propionic acid is also used in the development of new drugs targeting proteasome inhibition for cancer treatment. By incorporating this compound into the synthesis of potential drug candidates, researchers can create novel molecules with improved pharmacological properties, such as increased stability, better bioavailability, and reduced toxicity. This can ultimately lead to the discovery of more effective and safer antitumor agents for clinical use.
Check Digit Verification of cas no
The CAS Registry Mumber 96363-20-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,3,6 and 3 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 96363-20:
(7*9)+(6*6)+(5*3)+(4*6)+(3*3)+(2*2)+(1*0)=151
151 % 10 = 1
So 96363-20-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H21NO5/c1-15(2,3)21-14(19)16-12(9-13(17)18)10-5-7-11(20-4)8-6-10/h5-8,12H,9H2,1-4H3,(H,16,19)(H,17,18)/p-1/t12-/m1/s1
96363-20-1Relevant articles and documents
ARYLAMIDES
-
Page/Page column 77, (2010/02/06)
The invention relates to compounds of formula (I), to a method for their production, to pharmaceutical compositions containing said compounds and to their use for the treatment and/or prophylaxis of human or animal diseases, in particular bacterial infections.
